Epoprostenol
Epoprostenol Sodium is a prescription injectable drug administered intravenously to dilate blood vessels, often used for conditions like pulmonary hypertension. It comes as a lyophilized powder in vials with strengths of 0.5 mg or 1.5 mg, manufactured by Sun Pharmaceutical Industries, Inc. under ANDA210473. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Epoprostenol Sodium is a prescription injectable drug administered intravenously to dilate blood vessels, often used for conditions like pulmonary hypertension. It comes as a lyophilized powder in vials with strengths of 0.5 mg or 1.5 mg, manufactured by Sun Pharmaceutical Industries, Inc. under ANDA210473. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Epoprostenol",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Epoprostenol — ANDA 210473 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210473"
}
]
|
| identifier | ANDA210473 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Epoprostenol |
